title: Licensing drugs for diabetes.
authors.forename: Richard
authors.initials: R
authors.lastname: Lehman
authors.forename: John S
authors.initials: JS
authors.lastname: Yudkin
authors.forename: Harlan
authors.initials: H
authors.lastname: Krumholz
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000600:supply & distribution*; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects / Q000600:supply & distribution*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone